Neoadjuvant hormonal treatment of post-menopausal women who have operable breast cancer and whose tumors express hormonal estrogen receptors (ER) or progesterone receptors (PgR), or both
Phase of Trial: Phase IV
Latest Information Update: 16 Aug 2007
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 16 Aug 2007 Status changed from recruiting to completed.
- 28 Mar 2006 New trial record.